Scinovex
article Open AccessTop 1% cited

Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial

PLoS Medicine · 2005 · Vol. 2(11) · pp. e298–e298
Bertran AuvertDirk TaljaardEmmanuel LagardeJoëlle Sobngwi-TambekouRémi SittaAdrian Puren

Abstract

Male circumcision provides a degree of protection against acquiring HIV infection, equivalent to what a vaccine of high efficacy would have achieved. Male circumcision may provide an important way of reducing the spread of HIV infection in sub-Saharan Africa. (Preliminary and partial results were presented at the International AIDS Society 2005 Conference, on 26 July 2005, in Rio de Janeiro, Brazil.).

Genital Health and DiseaseUrologic and reproductive health conditionsUrological Disorders and TreatmentsMedicineRandomized controlled trialMale circumcisionHuman immunodeficiency virus (HIV)Clinical trialPopulationInternal medicineFamily medicineHealth servicesEnvironmental health

MeSH terms

AdolescentAdultCircumcision, MaleHumansMaleSexual BehaviorSouth AfricaUrban PopulationHealth BehaviorHIV-1HIV InfectionsTreatment OutcomeCondoms

Funding

  • Sidaction
  • Medical Research Council
Citations
2,445
FWCI
107.63
field-weighted impact
References
38
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.